21-hydroxylase deficiency
CYP21B
|
IVS2-13C>G |
-19 |
No |
Details
|
21-hydroxylase deficiency
CYP21B
|
IVS2-13C>G |
-33 |
No |
Details
|
Acute intermittent porphyria
HMBS
|
IVS8-1G>T |
-15 |
No |
Details
|
Adenosine deaminase deficiency
ADA
|
IVS10-34G>A |
-32 |
No |
Details
|
Alpha-mannosidosis
MAN2B1
|
IVS5-1G>C |
+15 |
No |
Details
|
Alpha-mannosidosis
MAN2B1
|
IVS14-2A>G |
+31 |
No |
Details
|
Alport syndrome
COL4A5
|
IVS29-5269A>G |
-5268 |
No |
Details
|
Amyotrophic lateral sclerosis
SOD1
|
IVS4-10T>G |
-9 |
No |
Details
|
Androgen insensitivity
AR
|
IVS2-11T>A |
-69 |
No |
Details
|
Antithrombin deficiency, type I
SERPINC1
|
IVS4-14G>A |
-12 |
No |
Details
|
APOE deficiency
APOE
|
IVS3-2A>G |
-52 |
Yes |
Details
|
Arrhytmogenic right ventricular cardiomyopathy
PKP2
|
IVS12-1G>C |
+17 |
No |
Details
|
Arrhytmogenic right ventricular cardiomyopathy
PKP2
|
IVS12-1G>C |
-160 |
No |
Details
|
Arrhytmogenic right ventricular cardiomyopathy
PKP2
|
IVS12-1G>C |
-160 |
No |
Details
|
Ataxia telangiectasia
ATM
|
IVS29-1G>A |
+1 |
No |
Details
|
Ataxia telangiectasia
ATM
|
IVS47-9G>A |
-7 |
No |
Details
|
Ataxia telangiectasia
ATM
|
IVS21-2A>G |
+32 |
No |
Details
|
Ataxia telangiectasia
ATM
|
IVS64-1G>C |
+13 |
Yes |
Details
|
Ataxia telangiectasia
ATM
|
IVS11-2A>G |
+7 |
No |
Details
|
Ataxia telangiectasia
ATM
|
IVS38-2A>C |
+61 |
No |
Details
|
Ataxia telangiectasia
ATM
|
IVS16-10T>G |
-9 |
No |
Details
|
Ataxia telangiectasia
ATM
|
IVS32-12A>G |
-11 |
No |
Details
|
Ataxia telangiectasia
ATM
|
IVS37-5delTCTA |
+7 |
No |
Details
|
Autoimmune lymphoproliferative syndrome
APT1
|
IVS4-1G>C |
+22 |
No |
Details
|
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
AIRE
|
IVS5-5delCTC |
-43 |
No |
Details
|
Autosomal dominant optic atrophy
OPA1
|
IVS25-9A>G |
+39 |
No |
Details
|
Autosomal dominant optic atrophy
OPA1
|
IVS20-1G>A |
+1 |
No |
Details
|
Autosomal dominant optic atrophy
OPA1
|
IVS9-1G>T |
+21 |
No |
Details
|
Autosomal dominant optic atrophy
OPA1
|
IVS26-1G>T |
+4 |
No |
Details
|
Autosomal dominant polycystic kidney disease
PKD1
|
IVS13-2A>T |
+74 |
No |
Details
|
Autosomal dominant retinitis pigmentosa
PRPF31
|
IVS5-1G>A |
+1 |
No |
Details
|
Autosomal recessive primary microcephaly
CDK5RAP2
|
IVS26-15A>G |
-14 |
No |
Details
|
Autosomal recessive retinitis pigmentosa
PDE6B
|
IVS2-1G>T |
+12 |
No |
Details
|
Barth syndrome
TAZ
|
IVS1-2A>G |
+31 |
No |
Details
|
Batten disease
CLN3
|
IVS15-1G>T |
+5 |
Yes |
Details
|
B-cell chronic lymphocytic leukaemia
TP53
|
IVS7-2A>C |
-3 |
No |
Details
|
B-cell chronic lymphocytic leukaemia
TP53
|
IVS7-2A>C |
+24 |
No |
Details
|
Benign familial neonatal convulsions
KCNQ2
|
IVS14-6C>A |
-4 |
No |
Details
|
Beta-mannosidosis
MANBA
|
IVS15-2A>G |
+172 |
No |
Details
|
Beta-thalassemia
HBB
|
IVS2-3C>A |
-271 |
Yes |
Details
|
Beta-thalassemia
HBB
|
IVS2-2A>G |
-271 |
Yes |
Details
|
Beta-thalassemia
HBB
|
IVS1-21G>A |
-19 |
No |
Details
|
Beta-thalassemia
HBB
|
IVS1-15T>G |
-14 |
No |
Details
|
Biotinidase deficiency
BTD
|
E1+56G>A |
+57 |
No |
Details
|
Breast cancer
BRCA1
|
IVS5-12A>G |
-11 |
No |
Details
|
Breast cancer
BRCA1
|
IVS7-24del10 |
-59 |
No |
Details
|
Breast cancer
BRCA2
|
IVS23-2A>G |
+7 |
No |
Details
|
Breast/ovarian cancer
BRCA1
|
IVS11-2A>G |
-1 |
No |
Details
|
CD55 deficiency
DAF
|
E5+18C>T |
+44 |
No |
Details
|
Cerebral cavernous malformations
CCM2
|
c.205-1_2delinsT |
+7 |
No |
Details
|
Chitotriosidase deficiency
CHIT1
|
E10+20dup24 |
+103 |
No |
Details
|
Chronic granulomatous disease
CYBB
|
IVS4-15del36 |
-179 |
No |
Details
|
Citrullinemia
ASS1
|
IVS14-1G>C |
+7 |
Yes |
Details
|
Citrullinemia
ASS1
|
IVS15-1G>C |
+7 |
Yes |
Details
|
Coffin-Lowry syndrome
RSK2
|
IVS4-11A>G |
-10 |
No |
Details
|
Cohen syndrome
COH1
|
IVS51-1G>T |
+16 |
No |
Details
|
Colon tumor cell lines with microsatellite instability
ATM
|
IVS4-4del3T |
+22 |
No |
Details
|
Congenital hypogonadotropic hypogonadism
TAC3
|
c.209-1G>C (IVS3-1G>C) |
-22 |
No |
Details
|
Congenital hypothyroidism
SLC5A5
|
E13+67C>G |
+67 |
No |
Details
|
Congenital insensitivity to pain with anhidrosis
NTRK1 (TRKA)
|
IVS4-1G>C |
-41 |
No |
Details
|
Congenital myasthenia
CHRNE
|
IVS5-16G>A |
-14 |
No |
Details
|
Congenital myasthenia
CHRNE
|
IVS6-1G>C |
+2 |
No |
Details
|
Congenital myasthenia
CHRNE
|
IVS10-9dup16 |
-16 |
No |
Details
|
Craniometaphyseal dysplasia
ANKH
|
IVS9-4A>G |
-3 |
No |
Details
|
Crigler-Najjar syndrome, type I
UGT1A1
|
IVS4-1G>A |
+7 |
Yes |
Details
|
Crigler-Najjar syndrome, type I
UGT1A1
|
IVS3-2A>G |
+107 |
No |
Details
|
Cystic fibrosis
CFTR
|
IVS17a-26A>G |
-25 |
No |
Details
|
Cystic fibrosis
CFTR
|
E4+1G>T |
-183 |
No |
Details
|
Cystic fibrosis
CFTR
|
c.1002-1110_1113delTAAG |
-1162 |
No |
Details
|
Defect of N-/O-glycosylation, type IIe
COG7
|
c.170-7A>G (IVS2-7A>G) |
-6 |
No |
Details
|
Deoxyguanosine kinase deficiency
DGUOK
|
IVS3-62C>A |
-60 |
No |
Details
|
Dystonia
GCH1
|
IVS2-2A>G |
-1 |
No |
Details
|
Ehlers-Danlos syndrome
COL1A2
|
IVS5-2A>G |
+15 |
No |
Details
|
Ehlers-Danlos syndrome
COL1A2
|
IVS5-1G>C |
+15 |
No |
Details
|
Ehlers-Danlos syndrome
COL1A2
|
IVS5-1G>A |
+15 |
No |
Details
|
Ehlers-Danlos syndrome
COL5A1
|
IVS13-2A>G |
-100 |
No |
Details
|
Ehlers-Danlos syndrome
COL5A1
|
IVS4-2A>G |
+12 |
No |
Details
|
Ehlers-Danlos syndrome
COL5A1
|
IVS4-2A>G |
+15 |
No |
Details
|
Epidermolysis bullosa
COL17A1
|
IVS21-2A>C |
+27 |
No |
Details
|
Epidermolysis bullosa
COL17A1
|
IVS31-1G>T |
+9 |
No |
Details
|
Epidermolysis bullosa
COL17A1
|
IVS31-1G>T |
-69 |
No |
Details
|
Epidermolysis bullosa
COL17A1
|
IVS31-1G>T |
-264 |
No |
Details
|
Epidermolysis bullosa
COL17A1
|
IVS54-1G>A |
+1 |
No |
Details
|
Epidermolysis bullosa
ITGB4
|
IVS31-19T>A |
+38 |
No |
Details
|
Epidermolysis bullosa
KRT14
|
IVS2-2A>C |
+10 |
No |
Details
|
Epidermolysis bullosa
LAMC2
|
IVS3-1G>A |
+2 |
No |
Details
|
Epistasis in Bardet-Biedl syndrome
CCDC28B
|
E3+166C>T |
+5 |
No |
Details
|
Erythropoetic protoporphyria (partial ferrochelatase deficiency)
FECH
|
IVS4-4A>G |
-3 |
No |
Details
|
Erythropoetic protoporphyria (partial ferrochelatase deficiency)
FECH
|
IVS3-48T>C |
-63 |
No |
Details
|
Extrapyramidal movement disorder
TH
|
IVS11-24T>A |
-36 |
No |
Details
|
F5 deficiency
F5
|
IVS8-2A>G |
-24 |
No |
Details
|
Fabry disease
GLA
|
IVS3-1G>A |
+1 |
No |
Details
|
Fabry disease
GLA
|
IVS6-1G>A |
+1 |
Yes |
Details
|
Factor 12 deficiency
F12
|
IVS13-1G>A |
+1 |
Yes |
Details
|
Familial hypercholesterolemia
LDLR
|
IVS7-1G>C |
+17 |
No |
Details
|
Familial hypercholesterolemia
LDLR
|
IVS9-1G>A |
+7 |
No |
Details
|
Familial hypercholesterolemia
LDLR
|
IVS1-1G>C |
+10 |
No |
Details
|
Familial hypercholesterolemia
LDLR
|
IVS9-30GTGCTGATGdelinsCGGCT |
+54 |
No |
Details
|
Familial hypercholesterolemia
LDLR
|
E9+30C>A |
+31 |
No |
Details
|
Familial hypercholesterolemia
LDLR
|
IVS7-1G>C |
+17 |
No |
Details
|
Familial hypercholesterolemia
LDLR
|
c.1216C>A (E9, R385R)) |
+31 |
No |
Details
|
Familial hypercholesterolemia
LDLR
|
c.1359-1G>A (IVS9-1G>A) |
+7 |
No |
Details
|
Familial hyperinsulinemic hypoglycemia
ABCC8
|
IVS32-9G>A |
-7 |
No |
Details
|
Familial hyperinsulinemic hypoglycemia
ABCC8
|
IVS32-9G>A |
+20 |
No |
Details
|
Familial hyperinsulinemic hypoglycemia
ABCC8
|
IVS32-9G>A |
+30 |
No |
Details
|
Familial hyperinsulinemic hypoglycemia
ABCC8
|
IVS11-20A>G |
-73 |
No |
Details
|
Familial melanoma
CDKN2A
|
E1beta+354G>C |
+269 |
No |
Details
|
Familial thrombocytopenia
RUNX1
|
IVS3-1G>T |
+13 |
No |
Details
|
Fanconi anemia
FANCA
|
IVS15-1G>T |
-90 |
No |
Details
|
Gangliosidosis
GLB1
|
IVS14-2A>G |
-28 |
No |
Details
|
Gastrointestinal stromal tumors
KIT
|
IVS10-6del34 |
+27 |
No |
Details
|
Gastrointestinal stromal tumors
KIT
|
IVS10-6del30 |
+27 |
No |
Details
|
Gaucher disease
GBA
|
IVS7-13C>G |
-12 |
No |
Details
|
Glanzmann thrombasthenia
ITGA2B
|
IVS3-3del13 |
+18 |
No |
Details
|
Glanzmann thrombasthenia
ITGB3
|
E9+130G>A;E9+18C/A |
-5 |
No |
Details
|
Glucose-6-phosphate dehydrogenase deficiency
G6PD
|
IVS10-2A>G |
+9 |
No |
Details
|
Glycogen storage disease, type Ia
G6PC
|
E5+86G>T |
+91 |
Yes |
Details
|
Glycogen storage disease, type II
GAA
|
IVS1-13T>G |
+518 |
No |
Details
|
Glycogen storage disease, type III
AGL
|
IVS33+5G>A |
+53 |
No |
Details
|
Glycogenosis, type II
GAA
|
IVS6-22T>G |
-21 |
No |
Details
|
Glycogenosis, type VII
PFKM
|
IVS16-64A>G |
-63 |
No |
Details
|
Glycosylation deficiency
ALG8
|
IVS1-2A>G |
+11 |
No |
Details
|
GYPHe.NY
GYPB
|
E5+75C>G |
+75 |
Yes |
Details
|
GYPHe.P2
GYPB
|
E5+75C>G |
+95 |
Yes |
Details
|
Heart malformations
INVS
|
IVS13+2T>C |
+49 |
No |
Details
|
Hemophilia A
F8
|
c.1538-18G>A (IVS10-18G>A) |
+36 |
No |
Details
|
Hemophilia A
F8
|
E16+26G>A |
+47 |
No |
Details
|
Hemophilia A
F8
|
E11+32G>T |
+36 |
No |
Details
|
Hemophilia A
F8
|
IVS15+1G>T |
+47 |
No |
Details
|
Henshaw antigen
GPB
|
E5+65C>G |
+65 |
No |
Details
|
Henshaw antigen
GPB
|
IVS2-6T>G |
+60 |
No |
Details
|
Hepatic lipase deficiency
LIPC
|
IVS1-14A>G |
-78 |
No |
Details
|
Hepatic lipase deficiency
LIPC
|
IVS1-14A>G |
-13 |
No |
Details
|
Hereditary coproporphyria
CPO
|
IVS1-15C>G |
-14 |
No |
Details
|
Hereditary osteodystrophy
GNAS1
|
IVS7-1G>A |
+1 |
No |
Details
|
Hereditary spherocytosis
SPTA
|
IVS30-99C>T |
-70 |
No |
Details
|
Hermansky-Pudlak syndrome
HPS3
|
IVS16-1612G>A |
-1625 |
No |
Details
|
HLA-B*3916 allele
HLA-B
|
E3+17G>C |
+19 |
No |
Details
|
Hyper-parathyroididsm
HRPT2
|
IVS6-1delG |
-41 |
No |
Details
|
Hyper-parathyroididsm
HRPT2
|
IVS6-1delG |
+1 |
No |
Details
|
Hypertrophic cardiomyopathy
MYBPC3
|
IVS14-13G>A |
-11 |
No |
Details
|
Hypofibrinogenemia
FGB
|
E4+155T>A |
+116 |
No |
Details
|
Hypothyroidism
TPO
|
E8+367dupGGCC |
+7267 |
No |
Details
|
Hypoxanthine-guanine phosphoribosyltransferase deficiency
HPRT1
|
IVS9-2A>G |
+17 |
Yes |
Details
|
Hypoxanthine-guanine phosphoribosyltransferase deficiency
HPRT1
|
IVS9-1G>A |
+17 |
Yes |
Details
|
Hypoxanthine-guanine phosphoribosyltransferase deficiency
HPRT1
|
IVS9-2A>T |
+17 |
Yes |
Details
|
Hypoxanthine-guanine phosphoribosyltransferase deficiency
HPRT1
|
IVS9-16G>A |
-14 |
Yes |
Details
|
Hypoxanthine-guanine phosphoribosyltransferase deficiency
HPRT1
|
IVS9-3T>G |
-2 |
Yes |
Details
|
Hypoxanthine-guanine phosphoribosyltransferase deficiency
HPRT1
|
IVS7-1G>A |
+21 |
No |
Details
|
Hypoxanthine-guanine phosphoribosyltransferase deficiency
HPRT1
|
IVS1-2A>G |
+5 |
No |
Details
|
Hypoxanthine-guanine phosphoribosyltransferase deficiency
HPRT1
|
IVS5-1G>A |
+1 |
No |
Details
|
Infantile osteopetrosis
TCIRG1
|
IVS5-8G>A |
+11 |
No |
Details
|
Isovaleric acidemia
IVD
|
IVS7-1G>A |
-15 |
No |
Details
|
Keutel syndrome
MGP
|
IVS1-2A>G |
+13 |
No |
Details
|
Keutel syndrome
MGP
|
IVS1-2A>G |
+49 |
No |
Details
|
Kniest dysplasia
COL2A1
|
IVS21-2A>G |
+18 |
No |
Details
|
Laminopathy
LMNA
|
c.1609-12T>G (IVS9-12T>G) |
-11 |
No |
Details
|
Leukocyte adhesion deficiency
ITGB2
|
IVS6-14C>A |
-12 |
No |
Details
|
Li-Fraumeni syndrome
TP53
|
IVS5-1G>A |
+1 |
No |
Details
|
Li-Fraumeni syndrome
TP53
|
IVS5-11del11 |
+17 |
No |
Details
|
Li-Fraumeni syndrome
TP53
|
IVS3-11C>G |
-10 |
No |
Details
|
Li-Fraumeni syndrome
TP53
|
IVS3-1G>A |
+19 |
No |
Details
|
Li-Fraumeni syndrome
TP53
|
IVS9-1G>C |
-44 |
No |
Details
|
Lung cancer
TP53
|
IVS3-1G>C |
+19 |
No |
Details
|
Lysinuric protein intolerance
SLC7A7
|
IVS6-2A>T |
+10 |
No |
Details
|
Malonyl-CoA decarboxylase deficiency
MLYCD
|
IVS4-14A>G |
-13 |
No |
Details
|
Maple syrup urine disease
DBT
|
IVS4-17TTTdelinsAAA |
-17 |
No |
Details
|
Maturity-onset diabetes of the young
GCK
|
IVS5-1G>A |
-27 |
No |
Details
|
Maturity-onset diabetes of the young
TCF1(HCF-1A)
|
IVS7-6G>A |
-4 |
No |
Details
|
Maturity-onset diabetes of the young
TCF1(HCF-1A)
|
IVS4-2A>G |
+202 |
No |
Details
|
Metachromatic leukodystrophy
ARSA
|
E8+22C>T |
+27 |
Yes |
Details
|
Methionine synthase deficiency
MTR
|
IVS3-166A>G |
-165 |
No |
Details
|
Methionine synthase deficiency
MTR
|
IVS6-1670G>A |
-1672 |
No |
Details
|
Mitochondrial acetoacetyl-CoA thiolase deficiency
ACAT1
|
E5+46C>T |
+51 |
No |
Details
|
Mucolipidosis, type III gamma
GNPTG
|
IVS7-10G>A |
-8 |
No |
Details
|
Mucopolysaccharidosis, type I
IDUA
|
IVS2-3C>G |
-58 |
No |
Details
|
Mucopolysaccharidosis, type II
ICS
|
IVS3+1G>C |
+44 |
No |
Details
|
Mucopolysaccharidosis, type II
ICS
|
E3+5C>T |
+44 |
No |
Details
|
Mucopolysaccharidosis, type II
ICS
|
E4+1G>T |
+37 |
No |
Details
|
Mucopolysaccharidosis, type II
ICS
|
IVS3+1G>C |
+44 |
No |
Details
|
Mucopolysaccharidosis, type II
ICS
|
E3+5C>T |
+44 |
No |
Details
|
Mucopolysaccharidosis, type II
ICS
|
E4+1G>T |
+37 |
No |
Details
|
Mucopolysaccharidosis, type II
IDS
|
IVS3+1G>C |
+44 |
No |
Details
|
Mucopolysaccharidosis, type II
IDS
|
E4+1G>T |
+37 |
No |
Details
|
Mucopolysaccharidosis, type II
IDS
|
IVS6-2A>G |
+51 |
No |
Details
|
Mucopolysaccharidosis, type II
IDS
|
IVS3-2A>G |
-1 |
No |
Details
|
Mucopolysaccharidosis, type II
IDS
|
IVS7-1G>C |
+12 |
No |
Details
|
Multiple adenomatosis
APC
|
IVS7-17A>G |
-16 |
No |
Details
|
Multiple developmental abnormalities
TGFBR2
|
IVS1-2A>G |
+18 |
No |
Details
|
Muscle phosphofructokinase deficiency
PFKM
|
IVS6-2A>C |
+5 |
No |
Details
|
Muscle phosphofructokinase deficiency
PFKM
|
IVS6-2A>C |
+12 |
No |
Details
|
Muscular dystrophy
DMD
|
IVS74-2A>G |
+1164 |
No |
Details
|
Muscular dystrophy
DMD
|
IVS59-9T>A |
-7 |
No |
Details
|
Muscular dystrophy
DMD
|
IVS1+36846G>A |
+36997 |
No |
Details
|
Muscular dystrophy
DMD
|
IVS25+2036A>G |
+2131 |
No |
Details
|
Muscular dystrophy
DMD
|
IVS1+36947G>A |
|
No |
Details
|
Muscular dystrophy
DMD
|
IVS11-9A>G |
+8 |
No |
Details
|
Muscular dystrophy
DMD
|
IVS8-15A>G |
-14 |
No |
Details
|
Muscular dystrophy
DMD
|
IVS2+5591T>A |
+5638 |
No |
Details
|
Muscular dystrophy
DMD
|
IVS2+5591T>A |
+5724 |
No |
Details
|
Muscular dystrophy
DMD
|
E42+63T>G |
+63 |
No |
Details
|
Muscular dystrophy
DMD
|
IVS1+36947G>A |
-146561 |
No |
Details
|
Muscular dystrophy
DMD
|
IVS20-2A>G |
+7 |
No |
Details
|
Muscular dystrophy
DMD
|
IVS38-1G>A |
-45 |
No |
Details
|
Muscular dystrophy
LAMA2
|
IVS28-1G>C |
+69 |
No |
Details
|
Myeloperoxidase deficiency
MPO
|
IVS11-2A>C |
-109 |
Yes |
Details
|
Naevoid basal cell carcinoma syndrome
PTCH
|
IVS7-2A>C |
+16 |
No |
Details
|
Naevoid basal cell carcinoma syndrome
PTCH
|
IVS10-6ins21 |
-15 |
No |
Details
|
Netherton syndrome
SPINK5
|
IVS20-1G>A |
+1 |
No |
Details
|
Neurofibormatosis with malignant peripheral nerve sheath tumors
NF1
|
IVS40-5A>G |
-4 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS10a-9T>A |
-7 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS11-3C>G |
-43 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS39-279A>G |
-278 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS27b-2A>T |
+293 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS26-2A>T |
-14 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS26-2A>T |
-17 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS15-15A>G |
-14 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS15-12T>G |
-11 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS30-279A>G |
+278 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS31-5A>G |
-4 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS39-12T>A |
-10 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS15-16A>G |
-15 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS15-16A>G |
-15 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS15-15A>G |
-14 |
No |
Details
|
Neurofibromatosis, type I
NF1
|
IVS15-12T>G |
-11 |
No |
Details
|
Ocular albinism, type I
GPR143
|
IVS7-871G>A |
-869 |
No |
Details
|
Oculocutaneous albinism, type II
OCA2
|
IVS5-19A>G |
-18 |
No |
Details
|
Oligoadenylate synthase activity
OAS1
|
IVS6-1G>A |
+1 |
Yes |
Details
|
Oligoadenylate synthase activity
OAS1
|
IVS6-1G>A |
+98 |
Yes |
Details
|
Ornithine transcarbamylase deficiency
OTC
|
IVS4-2A>T |
+12 |
No |
Details
|
Osteogenesis imperfecta
COL1A2
|
IVS27-2A>G |
+46 |
No |
Details
|
Osteopetrosis
TCIRG1
|
IVS5-6C>A |
+11 |
No |
Details
|
Osteopetrosis
TCIRG1
|
E7+42G>A |
+42 |
No |
Details
|
Osteopetrosis
TCIRG1
|
IVS14-1G>A |
+183 |
No |
Details
|
Periodic fever syndrome
TNFRSF1A
|
IVS3-14G>A |
-12 |
No |
Details
|
Peutz-Jeghers syndrome
STK11
|
IVS1-2A>G |
-124 |
No |
Details
|
Peutz-Jeghers syndrome
STK11
|
IVS1-2A>G |
-113 |
No |
Details
|
Phenylketonuria
PAH
|
IVS10-11G>A |
-9 |
No |
Details
|
Phenylketonuria
PAH
|
IVS8-7A>G |
-6 |
No |
Details
|
Phenylketonuria
PAH
|
c.168-2A>G (IVS2-2A>G) |
-81 |
No |
Details
|
Poikilocytic anemia
SPTA1
|
IVS19-13T>G |
-12 |
No |
Details
|
Pseudohypoaldosteronism, type I
SCNN1G
|
IVS2-1G>A |
+6 |
No |
Details
|
Pyruvate dehydrogenase deficiency
PDHA1
|
IVS9-1G>A |
-121 |
No |
Details
|
Pyruvate kinase deficiency
PKLR
|
IVS3-2A>T |
+6 |
No |
Details
|
Pyruvoyl-tetrahydropterin synthase deficiency
PTPS
|
IVS1-3C>G |
+12 |
No |
Details
|
Rabson-Mendenhall's syndrome
INSR
|
IVS4-2A>G |
+12 |
No |
Details
|
Recessive dystrophic epidermolysis bullosa
COL7A1
|
IVS6-5del5 |
+13 |
No |
Details
|
Recessive dystrophic epidermolysis bullosa
COL7A1
|
IVS2-3C>G |
-70 |
No |
Details
|
Recessive hereditary spherocytosis
EPB42
|
E11+39G>T |
+41 |
No |
Details
|
Retinitis pigmentosa
RPGR
|
IVS13-8A>G |
-7 |
Yes |
Details
|
Retinitis pigmentosa
SAG
|
IVS10-25A>G |
-24 |
No |
Details
|
Retinoblastoma
RB1
|
IVS22-8T>A |
-6 |
No |
Details
|
Retinoblastoma
RB1
|
IVS7-9C>G |
-8 |
No |
Details
|
Retinoblastoma
RB1
|
IVS18-11A>G |
-10 |
No |
Details
|
Retinoblastoma
RB1
|
IVS12-3A>G |
-2 |
No |
Details
|
Retinoblastoma
RB1
|
g.161984T>A (IVS21-13T>A) |
-11 |
No |
Details
|
Retinoblastoma
RB1
|
g.76875A>G (IVS14-14A>G) |
-13 |
No |
Details
|
Retinoblastoma
RB1
|
g.149986T>G (IVS17-12T>G) |
-11 |
No |
Details
|
Retinoblastoma
RB1
|
g.64328A>G (IVS9-2A>G) |
-1 |
No |
Details
|
Rett syndrome
CDKL5
|
IVS13-1G>A |
+1 |
No |
Details
|
Rett syndrome
MECP2
|
IVS1-6C>G |
-5 |
No |
Details
|
Rhizomelic chondrodysplasia punctata
PEX7
|
IVS3-10A>G |
-9 |
No |
Details
|
Rothmund-Thomson syndrome
RECQL4
|
IVS12-1G>C |
+75 |
No |
Details
|
Sandhoff disease
HEXB
|
IVS12-26G>A |
-24 |
No |
Details
|
Sandhoff disease
HEXB
|
IVS10-17A>G |
-37 |
No |
Details
|
Sandhoff disease
HEXB
|
IVS10-17A>G |
+112 |
No |
Details
|
Sandhoff disease
HEXB
|
E11+8C>T |
+112 |
No |
Details
|
Severe combined immunodeficiency
ZAP70
|
IVS9-11G>A |
-9 |
No |
Details
|
Sjogren-Larsson syndrome (fatty aldehyde dehydrogenase deficiency)
FALDH (ALDH3A2)
|
IVS4-14T>A |
-24 |
No |
Details
|
Sjogren-Larsson syndrome (fatty aldehyde dehydrogenase deficiency)
FALDH (ALDH3A2)
|
IVS3-2A>G |
+33 |
No |
Details
|
Smith-Lemli-Opitz syndrome
DHCR7
|
IVS8-1G>C |
-134 |
Yes |
Details
|
Spastic paraplegia
SPG4
|
IVS6-1G>A |
+8 |
No |
Details
|
Stargardt disease
ABCR (ABCA4)
|
E16+1G>C |
+3 |
No |
Details
|
Stickler syndrome
COL2A1
|
IVS17-2A>G |
+16 |
No |
Details
|
Stickler syndrome
COL2A1
|
IVS23+135G>A |
-234 |
No |
Details
|
Supravalvular aortic stenosis
ELN
|
IVS15-3C>G |
-44 |
No |
Details
|
Syndromic short stature
LHX4
|
IVS4-1G>C |
+12 |
No |
Details
|
Syndromic short stature
LHX4
|
IVS4-1G>C |
+17 |
No |
Details
|
Thiopurine methyltransferase deficiency
TPMT
|
IVS9-1G>A |
-330 |
Yes |
Details
|
Thiopurine methyltransferase deficiency
TPMT
|
IVS9-1G>A |
-1 |
Yes |
Details
|
Townes-Brocks syndrome
SALL1
|
IVS2-19T>A |
-17 |
Yes |
Details
|
Tuberous sclerosis
TSC1
|
c.1030-3C>G |
-102 |
No |
Details
|
Tuberous sclerosis
TSC2
|
IVS9-3C>G |
+56 |
No |
Details
|
Tuberous sclerosis
TSC2
|
IVS38-18A>G |
+74 |
No |
Details
|
Tuberous sclerosis
TSC2
|
IVS9-15G>A |
+56 |
No |
Details
|
Turcot syndrome
PMS2
|
c.989-1G>T (IVS9-1G>T) |
+27 |
No |
Details
|
Ullrich congenital muscular dystrophy
COL6A2
|
IVS17-2A>G |
+28 |
No |
Details
|
Ullrich congenital muscular dystrophy
COL6A2
|
IVS12-10A>G |
-247 |
No |
Details
|
Ullrich congenital muscular dystrophy
COL6A2
|
IVS12-10A>G |
-64 |
No |
Details
|
Usher syndrome, type I
CDH23
|
c.3580-1G>T (IVS29-1G>T) |
+51 |
No |
Details
|
Usher syndrome, type I
CDH23
|
c.6050-9G>A (IVS45-9G>A) |
-7 |
No |
Details
|
Usher syndrome, type ID
CDH23
|
IVS45-9G>A |
-7 |
No |
Details
|
Usher syndrome, type II
USH2A
|
c.2168-1G>C (IVS12-1G>C) |
+7 |
No |
Details
|
Usher syndrome, type II
USH2A
|
c.7595-8C>G (IVS40-8C>G) |
-7 |
No |
Details
|
Variegate porphyria
PPOX
|
IVS7-9T>G |
-8 |
No |
Details
|
von Willebrand disease
F8
|
IVS13-3C>A |
-62 |
No |
Details
|
Werner's syndrome
WRN
|
IVS29-7T>A |
-5 |
No |
Details
|
Wilson disease
ATP7B
|
IVS7-8T>G |
-23 |
No |
Details
|
Wilson disease
ATP7B
|
IVS11-2A>G |
-39 |
No |
Details
|
Xeroderma pigmentosum
ERCC3
|
IVS14-6C>A |
-4 |
Yes |
Details
|
Xeroderma pigmentosum
XPA
|
IVS3-12A>G |
-11 |
No |
Details
|
Xeroderma pigmentosum
XPA
|
IVS3-1G>C |
+2 |
No |
Details
|
X-linked hydrocephalus
L1CAM
|
IVS17-19A>C |
-69 |
No |
Details
|
X-linked hydrocephalus, MASA syndrome, spastic paraplegia
L1CAM
|
IVS26-12G>A |
-10 |
No |
Details
|
X-linked hyper-IgM syndrome
TNFSF5(HIGM1)
|
IVS4-2A>G |
+8 |
No |
Details
|
X-linked mental retardation
FACL4
|
IVS10-2A>G |
-28 |
No |
Details
|
X-linked recessive myotubular myopathy
MTM1
|
IVS12-10A>G |
-9 |
No |
Details
|